ANAB News
Archived Headlines
- AnaptysBio, an inflammation biotech, prices upsized $75 million IPO at $15 midpoint 01/26/17
- US IPO Week Ahead: AppDynamics headlines rush of 8 IPOs 01/20/17
- 7 US IPOs join next week's calendar; 2 deals launch Wednesday morning for week of 1/30 01/18/17
- Allergy biotech AnaptysBio sets terms for $60 million IPO 01/17/17
- Breathe easy: AnaptysBio files for a $86 million IPO 09/09/15
2017 IPO state rankings: California clings to #1 spot with TX and NY close behind
Driven by Silicon Valley, California is again the most active state for 2017 IPO activity with 26 offerings so far this year. The group averages an impressive 44% return, including three deals that are up...read more
Biotechs stage comeback after slow quarter
The US IPO market snapped back in the 1Q17, but quarterly biotech activity fell to its lowest level since the 4Q12. Just three of the 25 deals came from biotechs in the 1Q17, compared to seven of the eight in the 1Q16. Recent IPO Tocagen (TOCA)...read more
Renaissance Capital's 1Q17 US IPO Market Review
The US IPO market began 2017 with a far stronger start than the 1Q16. Momentum continued through the quarter, ending with 25 IPOs raising nearly $10 billion. A diverse set of companies from various sectors went public, ending biotech’s multi-year run as...read more
US IPO Weekly Recap: AppDynamics taken out, 6 IPOs price
The star was taken, but the show must go on. Six companies went public this week, but AppDynamics (APPD) was notably missing as Cisco (Nasdaq: CSCO) acquired it for $3.7 billion the night before its scheduled pricing. Cisco paid a 68%...read more